Waist-hip ratio and low HDL predict the risk of coronary artery disease in Pakistanis

Current Medical Research and Opinion

Volumn 20, Issue 1, 2004, Pages 55-62

  Nishtar, Sania ^a   Wierzbicki, Anthony S ^b   Lumb, Peter J ^b   Lambert Hammill, Michelle ^b   Turner, Charles N ^b   Crook, Martin A ^b   Mattu, Mohammad A ^c   Shahab, Saqib ^d   Badar, Asma ^a   Ehsan, Aayesha ^a   Marber, Michael S ^c   Gill, Jaswinder ^b  

^a Heartfile Pakistan   (Pakistan)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c PAKISTAN INSTITUTE OF MEDICAL SCIENCES   (Pakistan)

^d HEALTH SERVICES ACADEMY   (Pakistan)

Author keywords

Cardiovascular risk factor; Coronary heart disease; South Asian; Waist hip ratio

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; BODY MASS; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; ETHNIC GROUP; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; LIFESTYLE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PAKISTAN; PREDICTION; WAIST HIP RATIO;

ADULT; AGE FACTORS; AGED; BODY CONSTITUTION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CREATININE; DIABETES COMPLICATIONS; HUMANS; LIPOPROTEIN(A); LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PAKISTAN; REGRESSION ANALYSIS; RISK FACTORS;

EID: 9144265729     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079903125002595     Document Type: Article

References (45)

1. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97:596-601
2. Nishtar S. Prevention of coronary heart disease in south Asia. Lancet 2002;360:1015-18
3. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001;104:2855-64
4. Enas EA, Garg A, Davidson MA, Nair VM, Huet BA, Yusuf S. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J 1996;48:343-53
5. Economic survey of Pakistan 1998-99. Government of Pakistan, Finance Division, Economics Advisors Wing, Islamabad, 2000
6. Pakistan Medical Research Council. National Health Survey of Pakistan, 1990-94: Health Profile of the People of Pakistan. Islamabad: Network Publications Science, 1998
7. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606
8. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19
9. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41
10. Bhatnagar D, Anand IS, Durrington PN, et al. Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet 1995;345:405-9
11. Ramachandran A, Sathyamurthy I, Snehalatha C, et al. Risk variables for coronary artery disease in Asian Indians. Am J Cardiol 2001;87:267-71
12. Chambers JC, Eda S, Bassett P, et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 2001;104:145-50
13. Chambers JC, Obeid OA, Refsum H, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000;355:523-7
14. Chambers JC, Wander GS, Kooner JS. Homocysteine and coronary heart disease amongst Indian Asians. Indian Heart J 2000;52:S5-8
15. Chambers JC, Kooner JS. Homocysteine: a novel risk factor for coronary heart disease in UK Indian Asians. Heart 2001;86:121-2
16. Enas EA, Garg A, Davidson MA, Nair VM, Huet BA, Yusuf S. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J 1996;48:343-53
17. Sandholzer C, Saha N, Kark JD, Rees A, Jaross W, Dieplinger H, et al. Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arterioscler Thromb 1992;12:1214-26
18. Sattar NA, Gaw A. Risk of coronary heart disease in Asian women. Br Med J 1995;310:466-7
19. Hoogeveen RC, Gambhir JK, Gambhir DS, et al. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res 2001;42:631-8
20. Mohan V, Ravikumar R, Shanthi RS, Deepa R. Intimal medial thickness of the carotid artery in South Indian diabetic and non-diabetic subjects: the Chennai Urban Population Study (CUPS). Diabetologia 2000;43:494-9
21. Bhopal R, Unwin N, White M, et al. Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ 1999;319:215-20
22. Krishnaswami S, Prasad NK, Jose VJ. A study of lipid levels in Indian patients with coronary arterial disease. Int J Cardiol 1989;24:337-45
23. McKeigue PM, Marmot MG, Syndercombe Court YD, Cottier DE, Rahman S, Riemersma RA. Diabetes, hyperinsulinaemia, and coronary risk factors in Bangladeshis in east London. Br Heart J 1988;60:390-6
24. Bose K, Mascie-Taylor CG. Conicity index and waist hip ratio and their relationship with total cholesterol and blood pressure in middle-aged European and migrant Pakistani men. Ann Hum Biol 1998;25:11-16
25. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22
26. Nishtar S. Preventing coronary heart disease in South Asia. http://heartfile.org/append.htm (accessed July 2003)
27. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382-6
28. McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 1993;87:152-61
29. Kooner JS, Baliga RR, Wilding J, et al. Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature myocardial infarction. Arterioscler Thromb Vasc Biol 1998;18:1021-6
30. McKeigue PM. Metabolic consequences of obesity and body fat pattern: lessons from migrant studies. Ciba Found. Symp 1996;201:54-64
31. Case CC, Ballantyne CM. Statins and inflammatory markers. Curr Atheroscler Rep 2002;4:42-7
32. Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001;344:1959-65
33. Singh S, Dwivedi S, Melkani GC, et al. Lipoprotein(a) and coronary heart disease in Indian population. J Assoc Physicians India 1999;47:1157-60
34. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361;2005-16
35. Athyros VG, Papageorgiou AA, Elisaf M, Mikhailidis DP, on behalf of the GREACE Study Collaborative Group. Statins and renal function in patients with diabetes mellitus. Curr Med Res Opin 2003;19:54
36. Landray MJ, Thambyrajah J, McGlynn FJ, et al. Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis 2001;38:537-46
37. Reis SE, Olson MB, Fried L, et al. Mild renal insufficiency is associated with angiographic coronary artery disease in women. Circulation 2002;105:2826-9
38. Woo KS, Chook P, Young RP, Sanderson JE. New risk factors for coronary heart disease in Asia. Int J Cardiol 1997;62 (Suppl 1):S39-S42
39. Meigs JB, Jacques PF, Selhub J, et al. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 2001;24:1403-10
40. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97
41. Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association. Heart 1998;80(Suppl 2):S1-29
42. Sacks FM, Tonkin AM, Shepherd J, et al. Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project. Circulation 2000;102:1893-900
43. Rubins HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341:410-18
44. Wierzbicki AS, Mikhailidis DP. Beyond LDL-C - the importance of raising HDL-C. Curr Med Res Opin 2002;18:36-44
45. Wierzbicki AS. Statin therapy in people with diabetes and high-risk patients. Hosp Med 2003;64:16-19